Top compounds associated with response to DAND5


Feature Type Standardized
Nominal ANOVA
mRNA alisertib:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.15 2e-05
mRNA 16-beta-bromoandrosterone CTRPv2 pan-cancer AAC 0.16 2e-05
mRNA AZ-3146 CTRPv2 pan-cancer AAC 0.15 2e-05
mRNA Axitinib CTRPv2 pan-cancer AAC 0.14 2e-05
mRNA BRD-K27188169:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.21 3e-05
mRNA NVP-231 CTRPv2 pan-cancer AAC 0.13 3e-05
mRNA itraconazole CTRPv2 pan-cancer AAC 0.16 3e-05
mRNA YK 4-279 CTRPv2 pan-cancer AAC 0.13 4e-05
mRNA Ki8751 CTRPv2 pan-cancer AAC 0.14 5e-05
mRNA indisulam CTRPv2 pan-cancer AAC 0.13 5e-05
Download CSV